Pinnachem LLC , based in Virginia, has over 100 years of experience in the Active Pharmaceutical Industry as well as the fine chemicals industry.
G. Michael Laidlaw, PhD, is the Founder and President of Pinnachem, a company dedicated to serving the pharmaceutical, fine and specialty chemicals industries. Our services cover the areas of safety, compliance (FDA,DEA, EMEA and Kosher), technology transfers, market research and employee development.
Dr. Laidlaw was previously the President and Chief Operating Officer at Boehringer Ingelheim Chemicals from 2009-2010. During his tenure, the site was successfully audited by the US FDA, Japanese FDA, and EMEA from Europe as well as the Drug Enforcement Agency. Also during this time, the site capacity was expanded by 50% through a $150 million capital expansion; a strong safety culture was implemented resulting in the the site culture now being implemented world-wide within the Boehringer Ingelheim group.
Dr. Laidlaw was also associated with BASF Corporation from 1984 to 2006 and was the Site Manager for: an ethylene oxide/ propylene oxide non ionic surfactant plant; a chemicals(dyes and fine chemicals) and APIs (UV absorbers including sunscreen APIs) plant; and Team Leader for Technology Transfer and start-up of a new specialty chemicals plant in Tampico, Mexico.